It has been reported that protein and/or activity levels of BACE1 become elevated in brains of sporadic AD patients [19-21,41] and 5XFAD mice [26,42-44] as disease progresses into the severer pathological stage with established amyloid plaques. This evidence concerns the gene BACE1 and Alzheimer disease.